知镜 Cognispect · 医学文献与研究工作台

DLQIad: A New Quality-of-Life Questionnaire for Patients with Atopic Dermatitis.

Tolino E, Di Guardo A, Gallo U, Bernardini N, Proietti I, Skroza N.
Journal of clinical medicine · 2026-11-07 · PMID 43030836

文献摘要

Background/Objectives : Atopic dermatitis (AD) is a chronic inflammatory skin disease that substantially impairs health-related quality of life (HRQoL). The Dermatology Life Quality Index (DLQI) is widely used, but it is a generic dermatology instrument and may not capture the full patient-reported burden of AD. This study developed an exploratory AD-specific questionnaire (DLQIad), evaluated its internal consistency, and compared its responsiveness with that of the DLQI in patients receiving dupilumab. Methods : In this real-life, single-centre observational study, 102 adults with moderate-to-severe AD completed the DLQIad and DLQI and underwent Eczema Area and Severity Index (EASI) assessment before and after 16 weeks of dupilumab treatment. Pre-post differences were evaluated using Wilcoxon signed-rank tests. Internal consistency was assessed using Cronbach's alpha. Responsiveness was quantified using the standardised response mean (SRM) and the standardised mean-change effect size, and paired patient-level bootstrap resampling was used to compare the DLQIad and DLQI. Results : Mean EASI decreased from 27.84 to 5.96, mean DLQI from 15.76 to 2.35, and mean DLQIad from 44.24 to 8.19 (all p p = 0.009). The corresponding difference in standardised mean-change effect size was 0.362 (BCa 95% CI, -0.014-0.762; p = 0.065). Changes in EASI were significantly associated with changes in both patient-reported instruments, without a significant difference between their standardised regression coefficients. Conclusions : The DLQIad demonstrated high internal consistency and preliminary evidence of responsiveness in this selected cohort. Its apparent advantage over the DLQI was dependent on the responsiveness metric used. Structural validity, test-retest reliability, interpretability, and score thresholds require evaluation in independent multicentre samples before clinical implementation.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。